Valganciclovir (hydrochloride) (Standard)

• UNSPSC Description:

  Valganciclovir (hydrochloride) (Standard) is the analytical standard of Valganciclovir (hydrochloride). This product is intended for research and analytical applications. Valganciclovir hydrochloride is an orally active antiviral agent. Valganciclovir hydrochloride can inhibit the growth of adenoviruses and have a protective effect on immunosuppressed hamsters. Valganciclovir hydrochloride can be used for the research of Cytomegalovirus[1][2][3].

• Target Antigen:

  CMV

• Type:

  Reference Standards

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/valganciclovir-hydrochloride-standard.html

• Smiles:

  N[C@@H](C(C)C)C(OCC(OCN1C=NC2=C1N=C(N)NC2=O)CO)=O.[H]Cl

• Molecular Weight:

  390.82

• References & Citations:

  [1]Toth K, et al. Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters [J]. Viruses, 2015, 7(3): 1409-1428.|[2]Sugawara M, et al. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2 [J]. Journal of pharmaceutical sciences, 2000, 89(6): 781-789.|[3]Cvetkovic R S, et al. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients [J]. Drugs, 2005, 65: 859-878.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  175865-59-5